Results 171 to 180 of about 45,703 (244)

TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity. [PDF]

J Immunother Cancer
Sponheimer M, White K, Ulrich M, Kazerani M, Maiser A, Tyborski ET, Rappa GP, Richter D, Briem E, Hänel G, Philipp N, Nixdorf D, Rohrbacher L, Marcinek A, Linder A, Kuhl N, Piseddu I, Straub T, Harz H, Wichmann C, Maenner D, Rudelius M, Hornung V, Leonhardt H, Van Elssen CHMJ, Abdelhamed S, Diolaiti D, Bücklein V, Subklewe M.   +28 more
europepmc   +1 more source

ROSE12, a novel anti-CTLA-4 FcγRs binding-enhanced antibody activated by extracellular adenosine triphosphate, shows tumor-selective regulatory T-cell depletion and antitumor efficacy without systemic immune activation. [PDF]

J Immunother Cancer
Hayashi H, Tatsumi K, Katada H, Matsuda Y, Tsunenari T, Honda M, Nemoto T, Shimizu S, Miura-Okuda M, Ikuta Y, Ito A, Ogami C, Kato C, Kamimura M, Kibayashi T, Kubo C, Komatsu S, Komori Y, Shinozuka J, Susumu H, Tanno H, Tomii Y, Nakagawa K, Nagano H, Nanami M, Nishito Y, Fujisawa N, Matsushita T, Michisaka S, Yamazaki M, Yoshimoto M, Wakatsuki H, Wakabayashi T, Wada NA, Ueda O, Konishi H, Kashima K, Tanaka H, Endo M, Kitazawa T, Sakaguchi S, Kamata-Sakurai M, Igawa T.   +42 more
europepmc   +1 more source

A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies. [PDF]

Front Immunol
Veitonmäki N, Kostyn A, Kołt S, Ziemblicka A, Romanowska B, Oleksy S, Krzywińska E, Sołtys K, Świderski Ł, Naporowski P, Mamczur P, Świtoń M, Orłowski M, Zhang Y, Xu J, Andrzejczak A, Bielawska-Pohl A, Karabon L, Wołowiec D, Sime W, Massoumi R, Deshmukh S, Kołodziejski J, Klaus T, Spee P.   +24 more
europepmc   +1 more source

Integrin-specific binding macrocyclic RGD peptides functionalized with dinitrophenol as multivalent antibody-recruiting molecules to enhance cytotoxicity in cancer immunotherapy. [PDF]

RSC Med Chem
Cheng X, Hu C, Gao W, Chen Y, Wang W, Zhu G, Wu Z.   +6 more
europepmc   +1 more source

ADCC (No.68～72)

Japanese Journal of Clinical Immunology, 1978
openaire   +2 more sources

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques. [PDF]

, 2015
Alam, SM, Blair, L, Chao, A, Cocklin, SL, Dennison, SM, Duffy, R, Evans, A, Ferrari, G, Forthal, DN, Gao, F, Giorgi, EE, Haynes, BF, Kaewkungwal, J, Kim, JH, Klein, K, Korber, BT, Kumar, A, Landucci, G, Letvin, NL, Li, H, Liao, HX, Liu, P, Michael, NL, Montefiori, DC, Moody, MA, Moog, C, Nicely, NI, Nitayaphan, S, Pemble Iv, CW, Pitisuttithum, P, Pollara, J, Rerks-Ngarm, S, Robb, ML, Robinson, J, Santra, S, Schmitz, JE, Schutte, RJ, Shattock, RJ, Shaw, GM, Shen, X, Soderberg, KA, Tomaras, GD, Vidnovic, K, Warrier, R, Xia, SM, Zhang, R   +45 more
core   +1 more source

Analysis of clinicopathological features and clinical significance in 25 cases of mammary adenoid cystic carcinoma. [PDF]

BMC Womens Health
Xu X, Yu S, Qu W, Chen Y, Yang L.
europepmc   +1 more source

CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A. [PDF]

Clin Exp Immunol
Graham LV, Foxall RB, Ashton-Key M, Khakoo SI, Sayegh S, Leandro M, Reddy VR, Cragg MS, Blunt MD.   +8 more
europepmc   +1 more source

MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular Toxicity. [PDF]

Cancer Sci
Sato S, Yilmaz N, Arai S, Sakai K, Sato H, Murase Y, Ueda T, Koba H, Nanjo S, Tambo Y, Kotani H, Fukuda K, Taniguchi H, Amyot R, Flechsig H, Isozaki H, Matsumoto K, Yano S.   +17 more
europepmc   +1 more source

Altered natural killer cell function in children with severe malaria. [PDF]

Immunohorizons
Turyasingura G, Mellencamp KA, Namazzi R, Opoka RO, John CC, Hart GT.   +5 more
europepmc   +1 more source